Revvity has launched pHSense reagents, designed to advance internalisation studies in drug discovery.  

pHSense reagents are designed for high-throughput, plate-based workflows and intended for researchers studying G protein-coupled receptors (GPCRs) or antibody-drug conjugates (ADCs). 

Developed for use with standard plate readers, pHSense reagents combine a pH-sensitive dye and a time-resolved fluorescence (TRF) readout to allow for the delivery of robust kinetics of internalisation and high signal-to-background. They are compatible with Revvity’s multimode detection platforms. 

“pHSense reagents fill a critical gap in internalisation assay technologies, directed towards enabling researchers to gain faster, more reliable insights using more physiologically relevant conditions,” said Craig Monell, Senior Vice President, Reagents at Revvity.  

“With this launch, Revvity reinforces its commitment to advancing drug discovery through innovative tools that are focused on improving data quality, throughput, and reproducibility.”

Diana Turner, Senior Digital Content Editor, DDW